Concepedia

Catherine Sanders

CS

Statistics

Publications

31

Citations

5.8K

H-Index

24

Active since

1988

Affiliations

Adaptive Biotechnologies (United States)(Current)

Fred Hutch Cancer Center

Dana-Farber Cancer Institute

University of Mississippi Medical Center

The Ohio State University

Catherine Sanders is an author at Adaptive Biotechnologies (United States) specializing in immunology, oncology, and life sciences.

Publications per year

1988–2023

31

Publications

31

Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma

Timothy F. Cloughesy, Aaron Mochizuki, Joey Orpilla et al. · Nature Medicine · 2019 · 1.4K citations

Medicine, Immunology, Oncology +17

Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses

Yonit Lavin, Soma Kobayashi, Andrew M. Leader et al. · Cell · 2017 · 1.2K citations · Full text

Life Sciences, Immunology, Oncology +16

Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 Blockade

Douglas B. Johnson, Garrett M. Frampton, Matthew J. Rioth et al. · Cancer Immunology Research · 2016 · 493 citations · Full text

Medicine, Immunology, Oncology +17

ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial

John Wrangle, Vamsidhar Velcheti, Manish R. Patel et al. · The Lancet Oncology · 2018 · 426 citations

Medicine, Immunology, Oncology +12

Fractionated Radiation Therapy Stimulates Antitumor Immunity Mediated by Both Resident and Infiltrating Polyclonal T-cell Populations when Combined with PD-1 Blockade

Simon J. Dovedi, Eleanor J. Cheadle, Amy L. Popple et al. · Clinical Cancer Research · 2017 · 367 citations · Full text

Medicine, Immunology, Oncology +17

1–5 of 31